Process for preparing pharmaceutical composition containing N-acyl-2,3-benzodiazepine derivatives as active ingredient
The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I) R stands for a C1-6 aliphatic acyl group optionall...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
26.08.1998
|
Edition | 6 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I) R stands for a C1-6 aliphatic acyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C1-4 alkylamino, di(C1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group, or by one or more halogen(s); or R is a benzoyl, cyclopropanecarbonyl, C1-5 alkylcarbamoyl or phenylcarbamoyl group; or R is absent when a double bond exists between the N(3) and C(4) atoms; R means hydrogen; or R is absent when a double bond exists between the N(3) and C(4) atoms; R means a C1-3 alkyl group; or R and R together stand for a methylene group and no double bond is present between the N(3) and C(4) atoms; R means hydrogen or a C1-4 aliphatic acyl group; R represents hydrogen; a C1-6 aliphatic acyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C1-4 alkylamino, di(C1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group or by one or more halogen(s); as well as a benzoyl, palmitoyl, cyclopropanecarbonyl, C1-5 alkylcarbamoyl or phenylcarbamoyl group; and the dotted lines represent valence bonds optionally being present, with the proviso that no double bond exists between the N(3) and C(4) atoms when both R and R stand for hydrogen. The compounds of the general formula (I) possess valuable central nervous system effects, particularly muscle-relaxant, anticonvulsive and neuroprotective action. Thus, they may be useful for the treatment of various diseases of central nervous system origin. |
---|---|
AbstractList | The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I) R stands for a C1-6 aliphatic acyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C1-4 alkylamino, di(C1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group, or by one or more halogen(s); or R is a benzoyl, cyclopropanecarbonyl, C1-5 alkylcarbamoyl or phenylcarbamoyl group; or R is absent when a double bond exists between the N(3) and C(4) atoms; R means hydrogen; or R is absent when a double bond exists between the N(3) and C(4) atoms; R means a C1-3 alkyl group; or R and R together stand for a methylene group and no double bond is present between the N(3) and C(4) atoms; R means hydrogen or a C1-4 aliphatic acyl group; R represents hydrogen; a C1-6 aliphatic acyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C1-4 alkylamino, di(C1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group or by one or more halogen(s); as well as a benzoyl, palmitoyl, cyclopropanecarbonyl, C1-5 alkylcarbamoyl or phenylcarbamoyl group; and the dotted lines represent valence bonds optionally being present, with the proviso that no double bond exists between the N(3) and C(4) atoms when both R and R stand for hydrogen. The compounds of the general formula (I) possess valuable central nervous system effects, particularly muscle-relaxant, anticonvulsive and neuroprotective action. Thus, they may be useful for the treatment of various diseases of central nervous system origin. |
Author | FERENC ANDRASI SANDOR FARKAS PAL BERZSENYI |
Author_xml | – fullname: FERENC ANDRASI – fullname: SANDOR FARKAS – fullname: PAL BERZSENYI |
BookMark | eNqFjb0KwkAQhK_Qwr9n8B7AK2IqSwmKVbCwl_Wy0YVkd7k7A-bpvYC9w8B8xQyzNDMWxoUZrkE8xmhbCVYDKgTip9UXhB48vhN56KyXXiVSIuHMnIB4atUO_Kdz-13pHsijNAQjKjHaBgMNkGjAaCHbT2jzJmBDyGlt5i10ETe_XJnt-XSrLg5V7hg1XzOme1UXxaHIOpb_G1_cQUcJ |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
Edition | 6 |
ExternalDocumentID | CN1191111A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CN1191111A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:25:19 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CN1191111A3 |
Notes | Application Number: CN19981003976 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19980826&DB=EPODOC&CC=CN&NR=1191111A |
ParticipantIDs | epo_espacenet_CN1191111A |
PublicationCentury | 1900 |
PublicationDate | 19980826 |
PublicationDateYYYYMMDD | 1998-08-26 |
PublicationDate_xml | – month: 08 year: 1998 text: 19980826 day: 26 |
PublicationDecade | 1990 |
PublicationYear | 1998 |
RelatedCompanies | GYOGYSZERKUTATO INTEZET K V |
RelatedCompanies_xml | – name: GYOGYSZERKUTATO INTEZET K V |
Score | 2.4878902 |
Snippet | The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Process for preparing pharmaceutical composition containing N-acyl-2,3-benzodiazepine derivatives as active ingredient |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19980826&DB=EPODOC&locale=&CC=CN&NR=1191111A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3PT8IwFH5BNOpNUYO_ezA72Ti3QXdZjGwQYsIgBg03snUtmJixwMTIX-9r2ZQLyw7LlnVp875-Tfd97wHcPUYN6XDhUiEjmzqMJ9SVjFFpSol0ZVmJ9nH3wmb3zXkZNUYVmJZeGJ0n9FsnR0REccR7rufr7H8TK9DaysVD_IG3Zk-doRcYSWkXQ0ZrGkHLaw_6Qd83fN_zQyN89VQeMzyed2AXF9FMYaH93lKelGyTUDpHsDfAttL8GCoircGBX9Zdq8F-r_jdjZcF8hYnsCwU_QQXmSSbC1U8MJ2QbLq5JU2UQLxQYRElQl-XfyAhjfjPJ7XubRqLdDXDmFiJDD9BEgzApc79vSARnnr2I_jOXCgpWH4Kt5320O9S7MD4b6zGflj21D6DajpLRR2IxHAxGZdu4rgOt1mUIMlHpsWZGVt2wzmH-rZWLrY_uoTDtUEPoda8gmo-_xLXyNB5fKMH9xdQJpnp |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1dT8IwFL1RNOKbogY_6YPZk41zG2wvi5EOggqDGDS8kX20YmLGAhMjv97bsikvLHtYtqxLm3t6mu6cewGu74K6sCLuUC4Ck1p2FFNH2DYVuhBIV4YRKx93z290Xq2nUX20BZPCC6PyhH6r5IiIqAjxnqn5Ov3fxPKUtnJ-G37grel9e-h6WlzYxZDRGprXdFuDvtdnGmMu8zX_xZV5zPB42IYdXGDbEgutt6b0pKTrhNI-gN0BtpVkh7DFkwqUWVF3rQJ7vfx3N17myJsfwSJX9BNcZJJ0xmXxwOSdpJP1LWkiBeK5CotIEfqq_APxaRD9fFLjxqQhT5ZTjIklT_ETJMYAXKjc33MS4KlmP4LvzLiUgmXHUGu3hqxDsQPjv7EaM7_oqXkCpWSa8CoQgeGi25FwYsuxItMOYiT5QDciWw8Ns26dQnVTK2ebH9Wg3Bn2uuPuo_98Dvsrsx7CrnEBpWz2xS-RrbPwSg30L7QKnNw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Process+for+preparing+pharmaceutical+composition+containing+N-acyl-2%2C3-benzodiazepine+derivatives+as+active+ingredient&rft.inventor=FERENC+ANDRASI&rft.inventor=SANDOR+FARKAS&rft.inventor=PAL+BERZSENYI&rft.date=1998-08-26&rft.externalDBID=A&rft.externalDocID=CN1191111A |